Management of common adverse effects of antipsychotic medications

Cited by (572)

Items 201–300 of 572

1. Cognitive function and treatment response trajectories in first-episode schizophrenia: evidence from a prospective cohort study
   Edward Millgate, Kira Griffiths, Alice Egerton, Eugenia Kravariti, Cecilia Casetta, J.F.W. Deakin, Richard Drake, Oliver David Howes, Laura Kassoumeri, Sobia Khan et al. · 2022 · BMJ Open
2. Antipsychotic medication use in association with quantitative heel ultrasound (QUS)
   Behnaz Azimi Manavi, Mohammadreza Mohebbi, Amanda L. Stuart, Julie Anne Pasco, Jason M. Hodge, D. Kavindi Weerasinghe, Rasika M. Samarasinghe, Lana J. Williams · 2023 · Bone Reports
3. Analytical Performance Evaluation of Three Point-of-Care CBC Analyzers for Management of Clozapine Therapy in Ambulatory Psychiatry Clinics
   Robert D. Maynard, Tony Funk, William Harrill, Jenny C. Jin, Dawn G. Smith, Gina Smith, Nichole L Korpi-Steiner · 2023 · The Journal of Applied Laboratory Medicine
4. Evaluation of quality of life in patients with schizophrenia: An inpatient social welfare institution-based cross-sectional study
   Aleksandra D. Petrovic, Ana M. Barjaktarevic, Olivera Z. Kostic, Jelena Dimitrijević, Sara S. Mijailovic, Andjela Gogic, Slobodan Јаnkovic, Marija V. Andjelkovic, Marijana Stanojević-Pirković, Katarina Parezanović-Ilić et al. · 2024 · Open Medicine
5. Second‐generation antipsychotic‐induced dystonia: Analysis using the Japanese Adverse Drug Event Report ( JADER ) database
   Takumi Ebina, Kunihiro Iwamoto, Masahiko Ando, Masashi Ikeda · 2025 · Psychiatry and Clinical Neurosciences
6. Focused ultrasound-triggered escitalopram delivery using microbubble-liposome complexes for rapid and sustained serotonin regulation in depression therapy
   Chen-Cheng Tsai, Ching‐Hsiang Fan, Chia-Wei Lin, Ayache Bouakaz, Chih‐Kuang Yeh · 2025 · Biomedicine & Pharmacotherapy
7. Effects of several atypical antipsychotics closapine, sertindole or ziprasidone on hepatic antioxidant enzymes: Possible role in drug-induced liver dysfunction
   Lena Platanić Arizanović, Aleksandra Nikolić‐Kokić, Jelena M. Brkljačić, Nikola Tatalović, Marko Miler, Zorana Oreščanin-Dušić, Teodora Vidonja Uzelac, Milan R. Nikolic, Verica Milošević, Duško P. Blagojević et al. · 2020 · Journal of Toxicology and Environmental Health
8. Incidence of Orthostatic Hypotension in Schizophrenic Patients Using Antipsychotics at Sambang Lihum Mental Health Hospital, South Kalimantan
   Noor Cahaya, Sandra Putri Wijaya, Khoerul Anwar · 2021 · Borneo Journal of Pharmacy
9. Quantification of antipsychotic biotransformation in brain microvascular endothelial cells by using untargeted metabolomics
   Surachai Ngamratanapaiboon, Pracha Yambangyang · 2021 · Drug Discoveries & Therapeutics
10. Prescriptions of Antipsychotics in Younger and Older Geriatric Patients with Polypharmacy, Their Safety, and the Impact of a Pharmaceutical-Medical Dialogue on Antipsychotic Use
    Eva-Maria Gebauer, Albert Lukas · 2022 · Biomedicines
11. Antipsychotic medication use and fracture: a case–control study
    Behnaz Azimi Manavi, Amanda L. Stuart, Julie Anne Pasco, Jason M. Hodge, D. Kavindi Weerasinghe, Rasika M. Samarasinghe, Lana J. Williams · 2023 · Scientific Reports
12. Tolerability and safety outcomes of first-line oral second-generation antipsychotics in patients with schizophrenia
    Kristen M. Ward, Leslie Citrome · 2024 · Expert Opinion on Drug Safety
13. Current and Novel Approaches to Mitigate Cardiometabolic Adverse Effects of Second-Generation Antipsychotics
    Karolina Skonieczna‐Żydecka, Igor Łoniewski, Ewa Stachowska, Wojciech M. Marlicz, Christoph Ulrich Correll · 2020 · The International Journal of Neuropsychopharmacology
14. The role of sulpiride in attenuating the cardiac, renal, and immune disruptions in rats receiving clozapine: mRNA expression pattern of the genes encoding Kim-1, TIMP-1, and CYP isoforms
    Amany Tharwat Mohammed, Samah R. Khalil, Fagr A. Mahmoud, Gamal A. Elmowalid, Haytham Abdallah Ali, Hamed A. El‐Serehy, Mohamed M. Abdel‐Daim · 2020 · Environmental Science and Pollution Research
15. Comparison of Risk Factors of Falling for Psychiatric Inpatients and General Ward Inpatients Who Had Fallen
    Wen P. Chang, Hsiu‐Ju Jen · 2021 · Journal of the American Psychiatric Nurses Association
16. Depression and Suicide
    John D. Chovan · 2021
17. Oral Health in Individuals with Severe Mental Illness on Second‐Generation Antipsychotics—A Scoping Review
    Dileep Sharma, Oliver Higgins, Aleksander Sawicki, Poornima Ramamurthy, Belinda Field, Paul Hussein, Kiran A. Singh, Sarbin Ranjitkar · 2025 · Journal of Oral Pathology and Medicine
18. Do Asian and North American patients with bipolar disorder have similar efficacy, tolerability, and safety profile during clinical trials with atypical antipsychotics?
    Yuanhan Bai, Guanjie Chen, Haichen Yang, Keming Gao · 2019 · Journal of Affective Disorders
19. Screening of nanoemulsion components for asenapine maleate using validated RP-HPLC method
    Santosh Ashok Kumbhar, Chandrakanth Kokare, Birendra Shrivastava, Bapi Gorain · 2020 · Annales Pharmaceutiques Françaises
20. Prescriptions of antipsychotics dispensed in long-term care facilities during the COVID-19 pandemic
    Mir Masoom Ali, Iara Oliveira, Martin Blanco · 2022 · General Hospital Psychiatry
21. Antipsychotic drugs induce vascular defects in hematopoietic organs
    Zhao‐hua Deng, Jing Zhong, Hai‐lin Jiang, Hyun‐Woo Jeong, Jian‐wei Chen, Ya-Hai Shu, Ming Tan, Ralf H. Adams, Keping Xie, Qi Chen et al. · 2022 · The FASEB Journal
22. “InMotion”—Mixed physical exercise program with creative movement as an intervention for adults with schizophrenia: study protocol for a randomized controlled trial
    Hanna Poikonen, Anna Duberg, Mats H. Eriksson, Martin Eriksson Crommert, Majja Lund, Margareta Möller, Mussie Msghina · 2023 · Frontiers in Human Neuroscience
23. Falls and Fractures among Nursing Home Residents Treated with Pimavanserin versus Other Atypical Antipsychotics: Analysis of Medicare Beneficiaries with Parkinson’s Disease Psychosis
    Krithika Rajagopalan, Nazia Rashid, Daksha Gopal, Dilesh Doshi · 2024 · Drugs - Real World Outcomes
24. Orlistat for the treatment of antipsychotic-induced weight gain: an eight-week multicenter, randomized, placebo-controlled, double-blind trial
    Peng Xie, Tiannan Shao, Yujun Long, Weiwei Xie, Yangjun Liu, Ye Yang, Yuyan Huang, Renrong Wu, Qijian Deng, Hui Tang · 2024 · Lipids in Health and Disease
25. Reasons for disengagement in first-episode psychosis – perspectives from service users and their caregivers
    Yi Chian Chua, Kumarasan Roystonn, K. Pushpa, Swapna Kamal Verma, Charmaine Yu Zheng Tang · 2024 · BMC Psychiatry
26. Functional Connectivity Biomarkers in Schizophrenia
    Amber M. Howell, Alan Anticevic · 2024 · Advances in neurobiology
27. Pharmacist-led Si-care (schizophrenia care) model to improve medication adherence and symptom management in schizophrenia
    Noor Cahaya, Susi Ari Kristina, Anna Wahyuni Widayanti, James Green · 2024 · Exploratory Research in Clinical and Social Pharmacy
28. Drug-Induced Extrapyramidal Symptoms Scale of the Norwegian version: inter-rater and test–retest reliability
    Bernhard Weidle, Ashmita Chaulagain, Kenneth Stensen, Branko Aleksić, Norbert Skokauskas, Toshiya Inada · 2019 · Nordic Journal of Psychiatry
29. Dosing antipsychotics in special populations of patients with schizophrenia: severe psychotic agitation, first psychotic episode and elderly patients
    Fayçal Mouaffak, Florian Ferreri, Julie Bourgin, Emmanuelle Baloche, Olivier J. Blin, Pierre Vandel, Ricardo Pablo Garay, Pierre Vidailhet, Emmanuelle Corruble, Pierre‐Michel Llorca · 2021 · Expert Opinion on Pharmacotherapy
30. Olanzapine-Related Somnambulism
    Renato de Filippis, Daniel Guinart, Marianna Rania, Elvira Anna Carbone, Raffaele Gaetano, Cristina Segura‐Garcìa · 2021 · Journal of Clinical Psychopharmacology
31. Suppressing leukocyte Kv1.3-channels by commonly used drugs: A novel therapeutic target for schizophrenia?
    Yasuhiro Sato, Ryo KUWANA, Itsuro Kazama · 2022 · Drug Discoveries & Therapeutics
32. Switching Between Second-Generation Antipsychotics in Patients with Schizophrenia and Schizoaffective Disorder: 10-Year Cohort Study in Brazil
    Izabela Fulone, Marcus Tolentino Silva, Luciane Cruz Lopes · 2021 · Frontiers in Pharmacology
33. Case Report: Lesion network guided transcranial direct current stimulation targeting treatment refractory hallucinations and delusions: a traditional and accelerated stimulation case study
    Nicolas Raymond, Rebekah L. Trotti, Paulo L. Lizano · 2025 · Frontiers in Psychiatry
34. Role of adjunctive cariprazine for treatment-resistant depression in patients with major depressive disorder: A systematic review and meta-analysis of randomized controlled trials
    Eman Ali, Fakhar Latif, Yusra Mashkoor, Ayesha Sheikh, Amna Iqbal, Rabia Owais, Jawad Ahmed, Sadiq Naveed, Abdul Moeed, Irfan Ullah et al. · 2024 · Asian Journal of Psychiatry
35. Harnessing the therapeutic potential of Garcinia indica choisy constituents against olanzapine-induced cardiac and metabolic disorders
    Faizan A. Beerwala, Shruti V. Kolambkar, Adilmehadi. Karikazi, Nayeem Ashrafali Khatib, Vishwambhar Vishnu Bhandare, Subarna Roy, Darasaguppe Ramachandra Harish · 2025 · In Silico Research in Biomedicine
36. Surface Electromyography Combined with Artificial Intelligence in Predicting Neuromuscular Falls in the Elderly: A Narrative Review of Present Applications and Future Perspectives
    Yuandan Liao, Gang Tan, Hui Zhang · 2025 · Healthcare
37. The effectiveness of digital tools in physical activity interventions for individuals with severe mental illness: a scoping review
    Shannon Aisling Forde, Tara C. Coppinger, Susan Rea, Sinéad Hanrahan · 2025 · Disability and Rehabilitation Assistive Technology
38. Metagenome-based characterization of the gut virome in patients with schizophrenia
    Yi Ren, Pan Zhang, Hailong Yu, Shenghui Li, Hongli Jiang · 2025 · Journal of Translational Medicine
39. Antipsychotics and other risk factors for mortality among people with schizophrenia during an extreme heat event: a population-based case-control study
    Shirley X. Chen, Michael J. Lee, David A. McVea, Sarah B. Henderson · 2025 · Scientific Reports
40. Association between negative symptoms and health-related quality of life and functional outcomes in persons with schizophrenia: A systematic review
    Allyssa Chan, Andy Lu, Trisha Menon, Sabrina Wong, Kyle Valentino, Gia Han Le, Christine E. Dri, Roger S. McIntyre · 2026 · Schizophrenia Research
41. Herbal Therapies for Weight Gain and Metabolic Abnormalities Induced by Atypical Antipsychotics: A Review Article
    Hamideh Naghibi, Roshanak Salari, Mahdi Yousefi, Majid Khadem‐Rezaiyan, Mohammad Reza Ghanbarzadeh, Mohammad Reza Fayyazı Bordbar · 2023 · Current Drug Discovery Technologies
42. Sex-based influential factors for dental caries in patients with schizophrenia
    Mi Yang, Jingjing Xu, Xiaoqin Chen, Liju Liu, Di Kong, Yan Yang, Wei Chen, Zezhi Li, Xiangyang Zhang · 2023 · BMC Psychiatry
43. Comparison of brexpiprazole, aripiprazole, and placebo for Japanese major depressive disorder: A systematic review and network meta‐analysis
    Taro Kishi, Kenji Sakuma, Takeo Saito, Atsuo Nakagawa, Masaki Kato, Nakao Iwata · 2024 · Neuropsychopharmacology Reports
44. Dance/movement therapy for improving metabolic parameters in long-term veterans with schizophrenia
    Zhaoxia Zhou, Hengyong Guan, Meihong Xiu, Fengchun Wu · 2024 · Schizophrenia
45. Role of prolactin in the protective effect of amisulpride against 1,2-Diacetylbenzene’s neurotoxicity
    Ngoc Minh-Hong Hoang, Hai Duc Nguyen, Wonhee Jo, Min‐Sun Kim · 2024 · Environmental Toxicology and Pharmacology
46. Electroconvulsive therapy in the maintenance phase of psychotic unipolar depression
    Ahmed Al‐Wandi, Mikael Landén, Axel Nordenskjöld · 2024 · Acta Psychiatrica Scandinavica
47. Outcomes of surgery for inflammatory bowel disease among patients with psychiatric disorders
    Ayesha P. Ng, Giselle Moriah Porter, Amulya Vadlakonda, Nikhil L. Chervu, Aimal Khan, Peyman Benharash, Hanjoo R. Lee · 2024 · Journal of Gastrointestinal Surgery
48. Blood pressure targets, medication considerations and special concerns in elderly hypertension III: Focus on stroke and neurodegenerative disorders
    Cheng‐Hsuan Li, Sung‐Ju Hsueh, Li‐Kai Tsai, Wei Hung Chang, Shao‐Yi Cheng, Hao‐Min Cheng, Chih‐Fan Yeh, Yen-Hung Lin, Hsin-hsi C Tsai · 2025 · Journal of the Formosan Medical Association
49. A molecular mechanism mediating clozapine-enhanced sensorimotor gating
    Ioannis Mantas, Ivana Flais, Niclas Branzell, Tudor M. Ionescu, Eugene Kim, Xiaoqun Zhang, Diana Cash, Bastian Hengerer, Per Svenningsson · 2025 · Neuropsychopharmacology
50. Aripiprazole- and Lurasidone-Induced Akathisia: A Case Report and Literature Review
    Kalyan Kandra · 2025 · Cureus
51. Risk factors of falling among hospitalized patients with neurological disease – post-fall analysis
    Michaela Miertová, Ivana Bóriková, Martina Tomagová, Jaroslav Madleňák, Marián Grendár, Anna Barnau · 2021 · Medical Studies
52. Associations of common genetic risk variants of the muscarinic acetylcholine receptor M2 with cardiac autonomic dysfunction in patients with schizophrenia
    Alexander Refisch, Shoko Komatsuzaki, Martin Ungelenk, Ha‐Yeun Chung, Andy Schumann, Susann S. Schilling, Wibke Jantzen, Sabine Schröder, Thomas W. Mühleisen, Markus Maria Nöthen et al. · 2022 · The World Journal of Biological Psychiatry
53. Mapping the Knowledge of Antipsychotics-Induced Sudden Cardiac Death: A Scientometric Analysis in CiteSpace and VOSviewer
    Min Wang, Yixun Ma, Zefang Shen, Lufang Jiang, Xiaoyuan Zhang, Xuan Wei, Zhengqi Han, Hongxia Liu, Tiantong Yang · 2022 · Frontiers in Psychiatry
54. Molecular Findings Guiding the Modulation of the Endocannabinoid System as a Potential Target to Treat Schizophrenia
    Giuliana S. Zuccoli, Caroline Brandão‐Teles, Gabriela Maciel Vieira, Felipe V. Gomes, Fernanda Crunfli · 2022 · Advances in experimental medicine and biology
55. Dopaminergic and glutamatergic models of psychosis show differential sensitivity to aripiprazole and a novel experimental compound modulating D2/5-HT receptor activity
    Iveta Vojtěchová, Klara Tuckova, Radomír Jůza, Aleš Stuchlı́k, Eduard Kelemen, Jan Korábečný, Ondřej Soukup, Tomáš Petrásek · 2023 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
56. Fatty acid desaturase 1/2 (FADS1 and FADS2), fatty acid desaturase indices, and their relationships with metabolic syndrome in female adults with first-episode schizophrenia after antipsychotic medications
    Ying Liu, Xiaozhuang Jin · 2024 · Psychoneuroendocrinology
57. Pharmacotherapy management of schizophrenia for family physicians
    Japheth Bool, Alex Crawley, Annabelle Wanson, Breanna Davis, Katelyn Halpape · 2021 · Canadian Family Physician
58. Association between Anti-Psychotic Drugs Use and Hip Fractures in Patients with Dementia: A Nationwide Population-Based Study
    Chia-Hung Tang, Yi-Chen Lai, Yi‐Chen Chen, Shun-Min Chang, Yuhan Chen, Jung‐Yu Liao, Yi‐Chi Wang, Chung‐Han Ho, Ping‐Jen Chen · 2021 · International Journal of Environmental Research and Public Health
59. Nurse practitioner educational preparation and confidence related to managing antipsychotic medications and associated drug-induced movement disorders
    Shawn P. Gallagher, Lindsay Bouchard · 2023 · Journal of the American Association of Nurse Practitioners
60. Evaluation of Prescription Patterns of Antipsychotics in Schizophrenia Patients—A Single-Center Prospective Study
    Ahmed Mohamed, Abdulaziz Almulhim, Abdulrahman Abdullah Alnijadi, Fatimatuzzahra’ binti Abd Aziz, Khuloud Khaled Alajmi, Ahmed Abdullah Al-Mudhaffar, Mohammad Salem Almutairi · 2025 · Journal of Clinical Medicine
61. Tailored pharmacotherapy monitoring in Parkinson’s disease and Schizophrenia using a rapid and sensitive α-Synuclein assay
    Neelam Upadhyay, Manjari Tripathi, Rakesh Kumar Chaddha, Rashmi Ramachandran, Arunmozhimaran Elavarasi, Gururao Hariprasad, Ravikrishnan Elangovan · 2025 · Clinica Chimica Acta
62. Predictors of extrapyramidal side effects among patients taking antipsychotic medication at Mekelle psychiatry units, Northern Ethiopia, 2023: unmatched case-control study
    Welu Abadi Gebru, Gebregziabher Kidanemariam, Kenfe Tesfay Berhe, Tesfaye Derbie Begashaw, Hiwot Gebrewahid Reta, Hagos Tsegabrhan Gebreslassie · 2025 · BMC Psychiatry
63. Strategic and tactic use of antipsychotic medications in schizophrenia: a perspective on current prescription practice
    Marco De Pieri · 2025 · Discover Mental Health
64. Emerging Neurobiological and Therapeutic Insights into Schizophrenia: A Comprehensive Review
    Anamaria Oatu, Tudor-Florentin Capatina, Iulia-Cristina Mandras, Antonia Lucia Comșa, Simona Corina Trifu, Arina Cipriana Pietreanu · 2026 · International Journal of Molecular Sciences
65. The Role of Long-Acting Injectable Antipsychotics in the Early Treatment of Schizophrenia
    Sarah Jane Harrison, José Antunes, Karl Knight, Karen Johnston, Jordy Mehawej, Pedro Sanchez, Christoph Ulrich Correll · 2026 · CNS Drugs
66. Effect of Nurse-Led Screening Linked Brief Psycho-education for Improving Adherence to Antipsychotic Medications among Clients with Mental Illness
    Hemlata Ghatwal, Jaison Joseph, Purushottam Jangid · 2021 · Journal of Mental Health and Human Behaviour
67. Effectiveness of Providing Information on Antipsychotic Medication to Patients with Psychotic Disorders: An Integrative Review
    Margit Lappalainen, Marja Härkänen, Emilia Laukkanen, Lauri Kuosmanen · 2023 · Issues in Mental Health Nursing
68. Factors associated with risk of falling among younger inpatients in a mental health setting—A systematic review
    Irene Ngune, Seng Giap Marcus Ang, Gelaye Tadesse Nadew, Rosemary Saunders · 2023 · Journal of Clinical Nursing
69. A feasibility study of high intensity interval training intervention in inpatient mental health settings
    Rebecca Martland, Juliana Onwumere, Brendon Stubbs, Fiona Gaughran · 2024 · Psychiatry Research Communications
70. Clozapine-Related Functional Bowel Obstruction: A Rare Adverse Effect Unmasking Quetiapine and Benztropine Interaction Raising Need for Bowel Surveillance
    Apoorv Tiwari, Swathi Kambhatla, Nathan George, Prathyusha Anumolu, Nikhale Malik, Sujata Kambhatla · 2024 · ACG Case Reports Journal
71. Clinical characteristics associated with functioning trajectories following admission to a psychiatric institution: A prospective cohort study of individuals with psychosis
    Mélissa Beaudoin, Sabrina Giguère, Charles‐Édouard Giguère, Hind Ziady, Kingsada Phraxayavong, Stéphane Potvin, Alexandre Dumais · 2024 · Psychiatry Research
72. Health Perceptions and Risk of Metabolic Syndrome and Diabetes in Psychiatric Patients
    Şenay Öztürk, Elvan Emine Ata, Merve Sarıtaş · 2024 · Journal of Psychiatric and Mental Health Nursing
73. Safety assessment of deutetrabenazine: real-world adverse event analysis from the FAERS database
    Yanping Shu, Yuanhe Wang, Jiaoying Liu, Lingyan Hu, Sichao Tong, Gang Wu, Xianlin Zhu · 2024 · Frontiers in Pharmacology
74. Psychotropic Medication Use in 48, XXYY Syndrome
    Jessica Dreyer, Susan Howell, Samantha Bothwell, Kayla Molison, Alexandra Carl, Karli S. Swenson, Shanlee Davis, Gail Decker, GALAXY consortia, Nicole R. Tartaglia · 2025 · American Journal of Medical Genetics Part A
75. Schizophrenia and psychosis in children and adolescents: An inspiring journey of scientific progress and the rich influences of history and religion
    Donald E. Greydanus, Muhammad Waqar Azeem, Ahsan Nazeer · 2025 · Disease-a-Month
76. Safety of pharmacotherapy in the elderly patients with psychiatric diseases
    Oleg O. Kirilochev, Аделя Равильевна Умерова, Дорфман Инна Петровна, Svetlana E. Bataeva · 2020 · Clinical pharmacology and therapy
77. A Cross-Sectional, Questionnaire-Based Study on Drug Treatment Awareness in Schizophrenia Patients and Caregivers: An Unexplored Avenue
    Raakhi Tripathi, Sharmila Vinayak Jalgaonkar, Snehalata Vijayanand Gajbhiye, Nishtha Khatri, Mohsin Sayyed, Shubhangi Parkar · 2021 · Indian Journal of Psychological Medicine
78. Psychopharmacology
    Raffaella Zanardi, Marco Spangaro, F. Attanasio, Jacopo Sapienza, Francesca Martini, L. Fregna, Roberto Cavallaro, Cristina Colombo · 2022 · Springer eBooks
79. A comparison of efficacy, mechanism, and side effects of clozapine and risperidone in patients with schizophrenia
    B Hemalatha, E Ramnath, E Tamiljothi · 2022 · World Journal of Biology Pharmacy and Health Sciences
80. Quantitative Analysis of Tear Film in Patients on Atypical Antipsychotics
    V. Dixitha, B. A. Abhilash, H U Bhavya, Mahesh Babu, NA Sudhakar · 2023 · Ocular Immunology and Inflammation
81. Role of AI in ADME/Tox toward formulation optimization and delivery
    Ibtihag Yahya Elhag · 2023 · Elsevier eBooks
82. Clozapine-Associated Hypersexuality
    Te-En Chyou, Hsun Ou, San‐Yuan Huang · 2023 · American Journal of Therapeutics
83. Synthesis of multifunctional superparamagnetic mesoporous ZnMnFe2O4@Fe–CaSiO3 core-shell for medical applications
    Aqeel Al-Hamaidah, Mahmood Rezaee Roknabadi, M. Bagheri Harouni, Bizhan Malaekeh‐Nikouei, Asma Mahmoudi, Reza Ghanbari, Alireza Charmforoushan · 2023 · Materials Chemistry and Physics
84. Falls and Impaired Mobility
    Lotta J Seppala, Nathalie van der Velde · 2023 · Practical issues in geriatrics
85. Recent management of extrapyramidal syndrome in antipsychotic use
    Reisha Farahmadilah, Fazil Amris · 2023 · Jurnal Kedokteran Syiah Kuala
86. Schizophrenia and epigenetics: a comprehensive bibliometric analysis
    Abd Rahim Nour El Huda, Abdull Jalil Mohd Asyraf, A. Talib Norlelawati, Mat Rasid Siti Norain, Wan Salleh Wan Muhamad Salahudin, Azman Norainin Sofiya, Norbaiyah Mohamed Bakrim · 2023 · Middle East Current Psychiatry
87. Predictors of antipsychotics switching among ambulatory patients with schizophrenia in Ethiopia: a multicenter hospital-based cross-sectional study
    Mekdes Kiflu, Telake Azale, Kale Gubae, Samuel Agegnew Wondm, Ephrem Mebratu Dagnew, Asrat EliasErgena, Ousman Abubeker Abdela, Gizework Alemnew Mekonnen · 2024 · Annals of General Psychiatry
88. Enzyme Inhibition in Managing Cardiovascular Diseases
    Shivendra Kumar, Sunam Saha, Arockia M. Babu, Mohit Agrawal, Kuldeep Singh, Hema Chaudhary, Khushboo Lavania · 2024 · Current Enzyme Inhibition
89. Knowledge and use of art therapy for mental health treatment among clinical psychologists
    Eugenia Priscilla Doku Asare, Sandra Boatemaa Kushitor, Edward Kofi Sutherland, Millicent Ofori Boateng, Stephen Manortey · 2024 · PLoS ONE
90. Development of simultaneous determination of dopamine 2, histamine 1, and muscarinic acetylcholine receptor occupancies by antipsychotics using liquid chromatography with tandem mass spectrometry
    Gaku Akashita, Eriko Nakatani, Shimako Tanaka, Takashi Okura · 2024 · Journal of Pharmacological and Toxicological Methods
91. Potential risk analysis of antipsychotics-related constipation from the FDA Adverse Event Reporting System
    Sidi He, Chuanwei Li · 2025 · Expert Opinion on Drug Safety
92. ADVERSE EVENTS OF ANTIPSYCHOTICS AND CYTOCHROME POLYMORPHISMS: A CASE SERIES ON 31 PATIENTS
    Giuseppe Maina, Stefano Bramante, Antonio Borsotti, Francesco Oliva, Sylvia Rigardetto, Umberto Albert · 2021 · Psychiatria Danubina
93. Acute alithiasic pancreatitis following the use of Risperidone in a young man with schizophrenia: As a rare case report
    Marouane Boukroute, Soufyane El Kadiri, Manal Merbouh, Ghizlane El Aidouni, Houssam Bkiyar, Brahim Housni · 2023 · Radiology Case Reports
94. Atypical Antipsychotic Medications Disrupt the Cardio-Metabolic and Cardio-Immune Axes
    Bahman Rostama, Meghan A. May, KL Houseknecht · 2020 · Interventional Cardiology
95. Oral Healthcare in Patients with Schizophrenia
    Heeba Jabbar, Aarathi Vijayan · 2025 · Kerala Dental Journal
96. Editorial: Exercise and diet: strategies and prescriptions to improve mental and cognitive health
    Shengyan Sun, Paulo A. S. Armada-da-Silva, Yongcong Shao · 2024 · Frontiers in Psychiatry
97. Social Support and Level of Religiosity as Resilience Factors in Late Adult Widows
    Nadia Salsabila Munawwarah, Siti Nurjana Gani, Diah Karmiyati · 2024 · World Psychology
98. Symptomatic Treatment of Extrapyramidal Hyperkinetic Movement Disorders
    Gregory de Boer, Rob M. A. de Bie, Bart Erik Kris Sylvain Swinnen · 2024 · Current Neuropharmacology
99. The Effects of Antipsychotic Dose Reduction on Movement Disorders and Cardiometabolic Indices in Patients Remitted from a First Episode of Psychosis
    Yinzhao Liu, Iris E. Sommer, Marieke Begemann, Shiral S. Gangadin, Benjamin Ian Perry, Toon Anton Willem Scheurink, Nico J.M. van Beveren, Iris E. Sommer, Lieuwe de Haan, Wim Veling et al. · 2025 · Schizophrenia Bulletin
100. Brexpiprazole for agitation in alzheimer’s disease: A systematic review and meta-analysis of randomized controlled trials
     João Vítor Andrade Fernandes, João Victor de Oliveira Ramos, Laís Araújo dos Santos Vilar, Maurus Marques de Almeida Holanda · 2025 · Indian Journal of Psychiatry